Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Colgate Palmolive"


5 mentions found


Looking at the earnings calendar for next week, a tale of two types of consumer stocks emerges: the predictable and the volatile. We'll look at an options trade that could win if one of the volatile stocks surprises Wall Street. But also reporting are two of the most well known consumer staples stocks, Procter & Gamble (PG) and Colgate-Palmolive (CL) . There were few areas hit harder by the Covid lockdowns than consumer discretionary stocks in the travel, lodging and dining industries. The trade: LVS call spread The company's revenues have recovered meaningfully, but not completely.
Persons: LVS Organizations: Vegas, Procter, Gamble, Colgate, Palmolive, Procter & Gamble, Colgate Palmolive Locations: Marina Bay Sands, Singapore, Macao, Vegas
Morning Bid: Bank of Japan excites, Dow unlucky, Intel jumps
  + stars: | 2023-07-28 | by ( ) www.reuters.com   time to read: +4 min
Specifically, the central bank said it would offer to buy 10-year JGBs at 1.0% in fixed-rate operations, instead of the previous rate of 0.5% - tolerating the wider band for bond market borrowing rates. With July core inflation in Tokyo falling back to a 10-month low, the need for tightening may be ebbing anyway. Friday's data is expected to show another drop in the Fed's favoured core PCE inflation gauge in June. For markets more broadly, Friday seems a little scattergun so far after a heavy week of macro policy and corporate news. U.S. Treasury yields fell back from two-week highs hit after the punchy U.S. economy readouts and central bank moves, with the 2-to-10 year yield curve steepening as recession fears abate.
Persons: Mike Dolan, Dow Jones bluechips, T Rowe Price, Nick Macfie Organizations: Bank of Japan, Dow, Nikkei, Federal Reserve, European Central Bank, Treasury, ECB, Intel, U.S, Exxon Mobil, Chevron, Proctor, Gamble, Colgate Palmolive, Franklin Resources, Newell Brands, Church, Dwight, Charter Communications, Dallas Fed, University of Michigan, Reuters, Thomson Locations: U.S, Wall St, Tokyo, Wall, Asia, Centene, Franklin
Unilever’s new boss whets appetite for split
  + stars: | 2023-01-30 | by ( ) www.reuters.com   time to read: +2 min
LONDON, Jan 30 (Reuters Breakingviews) - Unilever’s new chief executive is arguably a bit low fat. The appointment of board member Hein Schumacher, CEO of Dutch dairy cooperative FrieslandCampina, will instead have investors wondering whether Unilever needs to split its food and non-food arms. Unilever’s current share price is barely 40 euros per share. (By Aimee Donnellan)Follow @Breakingviews on Twitter(The author is a Reuters Breakingviews columnist. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.
Morning Bid: Tech melts, buck bounces
  + stars: | 2022-10-28 | by ( ) www.reuters.com   time to read: +3 min
All of which raises some questions about the price at which Elon Musk eventually agreed to buy Twitter. But the dollar rallied on Friday as other central banks looked to more than match any easier Fed tilt. Eyes are shifting to another U.S. inflation update later, with European growth and inflation numbers surprising to the upside. Although spurred back higher on Friday by the inflation news, European bond markets had a dovish take on Thursday's doubling of European Central Bank interest rates to 1.5%. Key developments that should provide more direction to U.S. markets later on Friday:* U.S. September PCE price index, personal income and consumption.
UBS reiterates Apple as buy UBS said Apple's iPhone Pro and Pro Max demand remains "solid." Bank of America names Northrop Grumman and Rocket Lab top picks Bank of America said it likes Northrop's defensiveness. Bank of America reiterates Microsoft as buy Bank of America said it still sees a solid risk/reward outlook for Microsoft. Cowen reiterates Amazon as outperform Cowen said that its recent survey shows Amazon is still the preferred place for shopping. Stifel upgrades Biogen to buy from hold Stifel said in its upgrade of Biogen that concerns about the company's Alzheimer's drug, lecanemab, are overdone.
Total: 5